Vital Signs

This week's collection of news and events from the School of Medicine

UNC School of Medicine Celebrates Second Annual Class of Yang Family Biomedical Scholars

UNC School of Medicine Celebrates Second Annual Class of Yang Family Biomedical Scholars

The award, made possible through a donation from Lenovo chairman and CEO Yuanqing Yang, recognizes the research achievements of young tenured faculty.

UNC School of Medicine Celebrates Second Annual Class of Yang Family Biomedical Scholars - Read More…

Brownstein receives 2016 Fuller Award

Brownstein receives 2016 Fuller Award

Michelle Brownstein, MD, assistant professor of surgery, has been honored with this year’s H. Fleming Fuller Award, given annually to the member of the medical staff who most embodies Fuller’s lifelong commitment to patient care, teaching and community service.

Brownstein receives 2016 Fuller Award - Read More…

New investigational compound dramatically reduces sickle cell pain crises

New investigational compound dramatically reduces sickle cell pain crises

The drug, called SelG1, also reduced the frequency of pain crises in people with sickle cell disease and reduced the number of days they spent in the hospital.

New investigational compound dramatically reduces sickle cell pain crises - Read More…

UNC researchers ‘unravel’ Zika virus (watch video)

Researchers discuss Zika virus, transmission, and protection during Tuesday's UNC School of Medicine expert panel and community discussion.

UNC researchers ‘unravel’ Zika virus (watch video) - Read More…

Celebrity Poker Tournament in Charlotte will support UNC Angelman syndrome research

Celebrity Poker Tournament in Charlotte will support UNC Angelman syndrome research

On Saturday Dec. 10, 2016, Harvey’s Aces Celebrity Poker Tournament will be held at the Charlotte Museum of History. Proceeds will be donated to the Angelman Syndrome Foundation Clinic at Chapel Hill and the Harvey Baseball Foundation, two non-profit organizations that former professional baseball player Bryan Harvey helped create.

Celebrity Poker Tournament in Charlotte will support UNC Angelman syndrome research - Read More…

The purist: Chapel Hill man shares journey of HIV clinical trials at UNC

The purist: Chapel Hill man shares journey of HIV clinical trials at UNC

Robert Hill has been living with HIV for 22 years. Five years ago, he enrolled in a study at the UNC School of Medicine, which was part of Dr. David Margolis’ ‘kick and kill’ strategy for eradicating HIV by flushing it out of hiding with a drug called Vorinostat and killing it with either a vaccine or with immunotherapies.

The purist: Chapel Hill man shares journey of HIV clinical trials at UNC - Read More…

Ewend named President of UNC Physicians

Ewend named President of UNC Physicians

Matt Ewend, MD, FACS, has been named President of UNC Physicians. In this role, Ewend will oversee the physician clinical enterprise of UNC Health Care, which includes more than 2,400 physicians and 600 Advanced Practice Providers in 450 practices spanning the UNC Physicians Network, UNC Faculty Physicians, and physician practices at UNC Health Care affiliate hospitals.

Ewend named President of UNC Physicians - Read More…

'To seek a true cure’: UNC researchers pioneer HIV research with ‘kick and kill’

'To seek a true cure’: UNC researchers pioneer HIV research with ‘kick and kill’

In honor of World AIDS Day on Dec. 1, we take a look at the trailblazing ‘kick and kill’ method of attacking HIV to cure patients. UNC researchers have been working with GlaxoSmithKline on parallel studies at the UNC Cure Center for 18 months to advance this new method of combating the global epidemic of HIV.

'To seek a true cure’: UNC researchers pioneer HIV research with ‘kick and kill’ - Read More…

Can a smart patch prevent blood clots?

Can a smart patch prevent blood clots?

In lab experiments, North Carolina researchers developed the first patch to monitor blood viscosity and release blood thinning medication as needed.

Can a smart patch prevent blood clots? - Read More…

UNC clinical trials play crucial role in FDA approval for diabetes drug

UNC clinical trials play crucial role in FDA approval for diabetes drug

Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.

UNC clinical trials play crucial role in FDA approval for diabetes drug - Read More…